Linear Particle Accelerators Market: Introduction
Transparency Market Research has published a new report titled, ‘Global Linear Particle Accelerators Market’. According to the report, the global linear particle accelerators market was valued at US$ 2.3 Bn in 2019 and is projected to expand at a CAGR of 6% from 2023 to 2030. Linear accelerator is used to deliver external beam radiation for the treatment of cancer. The LINAC system customizes high-energy electrons to take the shape of the tumor to be treated, and destroy cancerous cells without affecting the surrounding tissues. Healthcare professionals such as radiation oncologists work in collaboration with dosimetrists and physicians to decide over the radiation treatment plan and appropriate mode of radiation treatment to be delivered.
Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46479
A LINAC system is programmed before each radiation therapy session to deliver high-energy X-rays. The radiation takes specific size & shape and tracks the location of a tumor. The system has built-in protective measures that are designed to prevent excess dosages delivered, which can be higher than the prescribed amount. Radiation therapists ensure that the intensity of radiation beam is constant by using a device called tracker.
Request for Analysis of COVID19 Impact on Linear Particle Accelerators Market –
In terms of type, the global linear particle accelerators market has been classified into low-energy machine, medium-energy machine, and high-energy machine. The low-energy machine segment captured the largest market share in 2019 and the trend is anticipated to continue during the forecast period. The segment is expected to be driven by increase in use of low-energy LINAC systems for treatment of breast cancer and rise in availability of low-energy LINAC systems. Based on end user, the global linear particle accelerators market has been categorized into hospitals, ambulatory care centers, and research centers. The hospitals segment held major share of the global market in 2019, owing to increase in installation of LINAC systems, demand for sophisticated treatment modalities for cancer, and use of linear accelerators for treatment of a broad range of tumors.
The increase in the global geriatric population is another factor driving the global linear particle accelerators market. According to Cancer Research U.K., people aged between 50 and 74 account for over half (53%) of all new cancer cases, with slightly more cases in males than females.
Buy Market Report –
Linear Particle Accelerators Market: Prominent Regions
North America held a major share of the global linear particle accelerators market in 2019. Increase in demand for integrated treatment solutions in oncology and shift from the use of traditional radiation therapy to LINAC are the key factors driving the market in the region. Europe held the second largest share of the global linear particle accelerators market in 2019. The growth of the linear particle accelerators market in the region can be attributed to high adoption of newer technology systems and increase in incidence of breast cancer. According to Globocon, in 2018, Europe had 4,229,662 cancer cases. Breast cancer accounted for nearly 12.4% of newly diagnosed cases in 2018. Incidence of breast cancer was higher among women than in men. Colorectal cancer and lung cancer accounted for nearly 11.8% and 10.6% of newly diagnosed cases in the same year.
Ask for Discount :
Linear Particle Accelerators Market: Key Players
Leading players are expanding their footprint to strengthen their positions in the global linear particle accelerators market. Development of innovative oncology systems, technological advancements, and geographic expansion by prominent market players are likely to present lucrative opportunities in the global linear particle accelerators market. Key players operating in the global linear particle accelerators market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Shinva Medical Instrument Co., Ltd., and Viewray Medical Technologies Inc.
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453